Gordon McKenzie

Michelson Diagnostics Ltd. develops medical imaging technology solutions. The firm develops, manufactures and markets VivoSight, a point-of-care, scanning device that provides clinicians with a unique, non-invasive tool for diagnosing a variety of skin pathologies. Its VivoSight uses light to provide continuous and accurate images of the sub-surface of the skin that can be easily interpreted by a clinician to assist in diagnosis and treatment guidance. The company was founded by Jonathan Denis Holmes, Martin Johns, Gordon McKenzie, Simon Richard Hattersley and Bill Gilkes in March 2006 and is headquartered in Maidstone, the United Kingdom.